Constance T. Albarracin
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies 36
- Cancer Genomics and Diagnostics 16
- Pathology and Forensic Medicine top 0.5%
- Breast Lesions and Carcinomas 36
- Oncology top 1%
- HER2/EGFR in Cancer Research 11
- Dermatology top 0.5%
- Cancer and Skin Lesions 20
- Reproductive Medicine top 2%
-
- BRCA gene mutations in cancer 12
-
- Salivary Gland Tumors Diagnosis and Treatment 9
-
- Growth Hormone and Insulin-like Growth Factors 8
- Co-authors
- Gabriel N. HortobágyiErika ResetkovaAna M. González-AnguloBanu ArunAdriana LópezVicente ValeroNour SneigeFunda Meric‐Bernstam
- Journals
- Journal of Biological Chemistry (1 paper)Journal of Clinical Oncology (9 papers)The Journal of Immunology (1 paper)
- Partner nations
- United StatesChinaUnited Arab Emirates
In The Last Decade
Constance T. Albarracin
121 papers receiving 5.1k citations
Peers
Comparison fields: 5 of 112
- Cancer Research 2.1k
- Pathology and Forensic Medicine 1.3k
- Oncology 1.7k
- Dermatology 532
- Reproductive Medicine 320
Countries citing papers authored by Constance T. Albarracin
This map shows the geographic impact of Constance T. Albarracin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Constance T. Albarracin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Constance T. Albarracin more than expected).
Fields of papers citing papers by Constance T. Albarracin
This network shows the impact of papers produced by Constance T. Albarracin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Constance T. Albarracin. The network helps show where Constance T. Albarracin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Constance T. Albarracin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 7 | |
| 4 | 2023 | 2 | |
| 5 | 2018 | 18 | |
| 6 | 2015 | 200 | |
| 7 | 2014 | 21 | |
| 8 | 2014 | 10 | |
| 9 | 2011 | 50 | |
| 10 | 2010 | 7 | |
| 11 | 2010 | 15 | |
| 12 | 2009 | 21 | |
| 13 | 2009 | 123 | |
| 14 | 2007 | 23 | |
| 15 | 2006 | 32 | |
| 16 | 2006 | 81 | |
| 17 | 2000 | 71 | |
| 18 | 1999 | 3 | |
| 19 | 1997 | 44 | |
| 20 | Furosemide unveils hidden tubule dysfunction induced by a short term treatment with cyclosporin A in isogenic minipigs | 1993 | 2 |
About Constance T. Albarracin
Constance T. Albarracin is a scholar working on Cancer Research, Dermatology and Pathology and Forensic Medicine, having authored 122 papers that have together received 5.2k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (36 papers), Breast Lesions and Carcinomas (36 papers), Cancer and Skin Lesions (20 papers), Cancer Genomics and Diagnostics (16 papers), BRCA gene mutations in cancer (12 papers), HER2/EGFR in Cancer Research (11 papers), Salivary Gland Tumors Diagnosis and Treatment (9 papers) and Growth Hormone and Insulin-like Growth Factors (8 papers). The work is most often cited by research in Cancer Research (2.1k citations), Pathology and Forensic Medicine (1.3k citations) and Oncology (1.7k citations). Constance T. Albarracin has collaborated with scholars based in United States, China and United Arab Emirates. Frequent co-authors include Gabriel N. Hortobágyi, Erika Resetkova, Ana M. González-Angulo, Banu Arun, Adriana López, Vicente Valero, Nour Sneige, Funda Meric‐Bernstam, Christopher I. Amos and Geula Gibori. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.